SABBY 13G MBRX 2.07.20

Company

Moleculin Biotech, Inc.

Filed

February 7, 2020

Accession Number

0001535610-20-000066

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →